XML 35 R5.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Consolidated Statements of Changes in Shareholders' Equity - USD ($)
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Total
Balance at Dec. 31, 2016 $ 316 $ 7,260,723 $ (8,409,096) $ (1,148,057)
Balance, shares at Dec. 31, 2016 31,660,827      
Options Expense 267,835 267,835
Common Stock Issued for cash $ 3 249,997 250,000
Common Stock Issued for cash, shares 250,000      
Common Stock Issued for Services $ 1 12,499 12,500
Common Stock Issued for Services, shares 50,000      
Warrant Expense        
Warrants issued for Debt Amendment 16,556 16,556
Warrants Exercised 250 250
Warrants Exercised, shares 25,000      
Net Income       288,983 288,983
Balance at Dec. 31, 2017 $ 320 7,807,860 (8,120,113) (311,933)
Balance, shares at Dec. 31, 2017 31,985,827      
Options Expense 37,456 37,456
Net Income 82,269 82,269
Balance at Mar. 31, 2018 $ 320 7,845,316 (8,037,844) (192,208)
Balance, shares at Mar. 31, 2018 31,985,827      
Balance at Dec. 31, 2017 $ 320 7,807,860 (8,120,113) (311,933)
Balance, shares at Dec. 31, 2017 31,985,827      
Warrant Expense        
Net Income         197,031
Balance at Sep. 30, 2018 $ 323 8,248,349 (7,923,082) 325,590
Balance, shares at Sep. 30, 2018 32,285,827      
Balance at Dec. 31, 2017 $ 320 7,807,860 (8,120,113) (311,933)
Balance, shares at Dec. 31, 2017 31,985,827      
Options Expense 169,828 169,828
Common Stock Issued for cash $ 12 799,988 800,000
Common Stock Issued for cash, shares 1,300,000      
Warrant Expense        
Warrants issued for Debt Amendment 7,444 7,444
Warrants for Acquisition of Community Specialty Pharmacy, LLC 170,291 170,291
Net Income       9,038 9,038
Balance at Dec. 31, 2018 $ 332 8,955,411 (8,111,075) 844,668
Balance, shares at Dec. 31, 2018 33,285,827      
Balance at Mar. 31, 2018 $ 320 7,845,316 (8,037,844) (192,208)
Balance, shares at Mar. 31, 2018 31,985,827      
Options Expense 50,616 50,616
Net Income 20,513 20,513
Balance at Jun. 30, 2018 $ 320 7,895,932 (8,017,331) (121,079)
Balance, shares at Jun. 30, 2018 31,985,827      
Options Expense 44,976 44,976
Common Stock Issued for cash $ 3 299,997 300,000
Common Stock Issued for cash, shares 300,000      
Warrants issued for Debt Amendment 7,444 7,444
Net Income 94,249 94,249
Balance at Sep. 30, 2018 $ 323 8,248,349 (7,923,082) 325,590
Balance, shares at Sep. 30, 2018 32,285,827      
Balance at Dec. 31, 2018 $ 332 8,955,411 (8,111,075) 844,668
Balance, shares at Dec. 31, 2018 33,285,827      
Options Expense 35,979 35,979
Common Stock issued for convertible debt and accrued interest $ 4 211,979 211,983
Common Stock issued for convertible debt and accrued interest, shares 423,966      
Warrants Exercised $ 1 165 166
Warrants Exercised, shares 16,666      
Net Income 125,229 125,229
Balance at Mar. 31, 2019 $ 337 9,203,534 (7,985,846) 1,218,025
Balance, shares at Mar. 31, 2019 33,726,459      
Balance at Dec. 31, 2018 $ 332 8,955,411 (8,111,075) 844,668
Balance, shares at Dec. 31, 2018 33,285,827      
Warrant Expense         26,363
Net Income         210,775
Balance at Sep. 30, 2019 $ 386 11,790,463 (7,900,300) 3,890,549
Balance, shares at Sep. 30, 2019 38,636,459      
Balance at Mar. 31, 2019 $ 337 9,203,534 (7,985,846) 1,218,025
Balance, shares at Mar. 31, 2019 33,726,459      
Options Expense 64,011 64,011
Net Income 57,981 57,981
Balance at Jun. 30, 2019 $ 337 9,267,545 (7,927,865) 1,340,017
Balance, shares at Jun. 30, 2019 33,726,459      
Options Expense 41,604 41,604
Common Stock Issued for cash $ 49 2,454,951 2,455,000
Common Stock Issued for cash, shares 4,910,000      
Warrant Expense 26,363 26,363
Net Income 27,565 27,565
Balance at Sep. 30, 2019 $ 386 $ 11,790,463 $ (7,900,300) $ 3,890,549
Balance, shares at Sep. 30, 2019 38,636,459